Uterine cancer
Conditions
Interventions
Gold Standard:Pathological examination
on 
and 
dual 
imaging 
technology
 
EKSPLA, 
Photosonus.
Sponsors
Zheng Xiangqin
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: (1) Patients with suspected clinical uterine tumor, such as abnormal uterine bleeding with obesity, hypertension, diabetes, delayed menopause, infertility or infertility, family history of endometrial cancer or colorectal cancer, Lynch syndrome, P53 mutation, inactivation of tumor suppressor genes P16, e-cadherin inactivation, and Her2/neu gene overexpression, etc.; (2) Patients with definite uterine tumor, but whose stage is unknown.
Exclusion criteria
Exclusion criteria: Patients with cervical cancer, ovarian cancer, vaginal cancer, or other non-female reproductive system malignant diseases, serious organ diseases, coagulation function abnormalities.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Image; | — |
Countries
China
Contacts
Public ContactLi Hui, Zheng Xiangqin
Fujian Province Maternity and Children's Hospital
Outcome results
None listed